Hilzinger Kurt J's Form 4 filing
Outlook Therapeutics, Inc. (OTLK) · filed Feb 23, 2022
- Accession no.
- 0001209191-22-012325
- Filed
- Feb 23, 2022
- Trade date
- Feb 22-23, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $257.0K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hilzinger Kurt JCIK 0001191504 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 22, 2022 | Common Stock | PPurchaseAcquired | +95,597 | $1.49 | +$142,439.53 | 118,714 | Direct | |
| Feb 23, 2022 | Common Stock | PPurchaseAcquired | +79,535 | $1.44 | +$114,530.4 | 198,249 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.